Prospective Study Evaluating Oncological Safety of Axillary Reverse Mapping
Open Access
- 6 March 2014
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (7) , 2197-2202
Abstract
Background Axillary reverse mapping (ARM) is a new technique developed with the aim of reducing lymphedema rates by preserving lymphatic drainage of the upper limbs during sentinel lymph node biopsy...Keywords
This publication has 31 references indexed in Scilit:
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trialTrials, 2013
- The Efficacy of Arm Node Preserving Surgery Using Axillary Reverse Mapping for Preventing Lymphedema in Patients with Breast CancerJournal of Breast Cancer, 2012
- Safety study of axillary reverse mapping in the surgical treatment for breast cancer patientsJournal of Cancer Research and Clinical Oncology, 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsCancer, 2010
- Axillary reverse mapping for breast cancerBreast Cancer Research and Treatment, 2009
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008
- Lymphedema in breast cancer survivors: Assessment and information provision in a specialized breast unitPatient Education and Counseling, 2007
- Morbidity of Sentinel Lymph Node Biopsy (SLN) Alone Versus SLN and Completion Axillary Lymph Node Dissection After Breast Cancer SurgeryAnnals of Surgery, 2007